These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9581211)

  • 1. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
    Sheline YI; Miller K; Bardgett ME; Csernansky JG
    Am J Geriatr Psychiatry; 1998; 6(2):155-61. PubMed ID: 9581211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J; Helkala EL; Kutvonen R; Lehtinen M; Riekkinen PJ
    Psychoneuroendocrinology; 1989; 14(1-2):89-95. PubMed ID: 2471986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
    Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H; Nyman H; Schalling D
    Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
    Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
    Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
    Kaye JA; May C; Daly E; Atack JR; Sweeney DJ; Luxenberg JS; Kay AD; Kaufman S; Milstien S; Friedland RP
    Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monoamine metabolites in old age dementias.
    Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
    Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
    Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
    Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Romani A; Pola A; Zerbi F; Savoldi F
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):79-86. PubMed ID: 2478368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Hildebrand J; Bourgeois F; Buyse M; Przedborski S; Goldman S
    Acta Neurol Scand; 1990 May; 81(5):427-30. PubMed ID: 1695809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
    J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF; Mohs RC; Davis KL
    Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y; Bardgett ME; Csernansky JG
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
    Martignoni E; Bono G; Blandini F; Sinforiani E; Merlo P; Nappi G
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):15-25. PubMed ID: 1712206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type.
    Volicer L; Direnfeld LK; Langlais PJ; Freedman M; Bird ED; Albert ML
    J Gerontol; 1985 Nov; 40(6):708-13. PubMed ID: 2997317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
    Freed DM; Corkin S; Growdon JH; Nissen MJ
    Neuropsychologia; 1988; 26(6):895-902. PubMed ID: 2461537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.